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Summary.-Lewis lung carcinoma cells were implanted in the foot-pads of mice and
the effects of the plasminogen-plasmin inhibitor tranexamic acid (t-AMCHA) and of
the plasminogen activator urokinase on metastasis were examined by electron
microscopy. The intravascular tumour cells were not associated with thrombus
formation in either control or urokinase-treated mice. Polymerized fibrin deposition
around tumour cells and thrombi composed of fibrin and platelets was observed only
in the mice given t-AMCHA. This suggests that the inhibition of fibrinolysis by tACC
caused fibrin deposition and thrombus formation around intravascular tumour cells,
which prevented release ofthe cells from primary foci to form secondary tumours. On
the other hand, fibrinolysis induced by urokinase prevented thrombus formation, and
accelerated cell release from primary foci.
HAEMATOGENOUS METASTASIS is a con-
tinuous process consisting of several
stages: (i) growth of primary tumours, (ii)
invasion of tumour cells into the vessels,
(iii) release and circulation of tumour cells
and (iv) lodgement and secondary growth
in distant organs. Several reports (Peter-
son, 1968; Tanaka et al., 1977; Clark,
1979; Donati et al., 1978) have suggested
that the coagulation-fibrinolysis system
plays different roles in the various stages
of metastasis. Some workers (Jones et al.,
1971; Warren & Vales, 1972; Chew &
Wallace, 1976; Kinjo, 1978) have demon-
strated the association of fibrin with
tumour-cell emboli in distant organs.
Fibrin formation may aid in tumour arrest
and adherence to blood vessel endothe-
lium. On the other hand, tumour-cell
release from primary foci is prior to cell
lodgement in the destination organs.
However, tumour-cell-fibrin interaction in
this stage is still unclear for lack of
adequate models. The previous study
(Tanaka et al., 1981) showed that the
plasminogen-plasmin inhibitor trans-4-
aminomethyl cyclohexane-1-carboxylic
acid (t-AMCHA, tranexamic acid) de-
creased, and the plasminogen activator
urokinase increased, the number of pul-
monary metastases of Lewis lung car-
cinoma. These effects were considered to
be mediated by the prevention and
enhancement of cell release, due to t-
AMCHA and urokinase, respectively.
The purpose of the present study is to
clarify the effects of t-AMCHA and
urokinase on the metastasis of Lewis lung
carcinoma. Tumour-cell invasion sites
were examined electron-microscopically,
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were used.
The experimental procedure has previously
been described (Tanaka et al., 1981). Lewis
lung carcinoma was passaged in male
C57BL/6 mice (Charles River Japan Inc.,
Atsugi, Japan). The gently homogenized cells
wvere filtered using 150 platinum mesh and
suspended in Hanks' balanced salt solution
at the rate of 106/ml, and 0-1 ml ofthe suspen-
sion was inoculated into the foot pads of 10
female BDFI mice (C57BL/6 x DBA/2) in
each group: the viability of the tumour cells
w-as 30%O according to the trypan-blue test.
The tumour-bearing legs were amputated 12
days after inoculation and the mice were
necropsied 23 days after transplantation.
Administrations of urokinase and t-AMCHA
wA-ere begun 1 day before inoculation and
continued until the day ofamputation: twice-
daily i.v. injections ofurokinase at a dosage of
10,000 u/kg, and oral administration of t-
AMCHA in the food, equivalent to a dose of
3 g/kg a day. Untreated mice inoculated wNith
the same number of cells were used as the
conltr'ol.
On Day 12, thie excised tumours Nere fixed
in 10% buffered formalin, processed for
paraffin section, and stained with haema-
toxylin and eosin, or W;;eigert fibrin stain. A
part of each tumour was frozen immediately
after the operation. Then, cryostat sections
were used for immunofluorescence studies,
using anti-mouse-fibrinogen rabbit serum and
fluorescein-conijugated anti-rabbit IgG goat
serum (Miles, Elkhart) for observation of
fibrin(ogen). The controls Awere obtained by
applying PBS or non-immunized rabbit
serum to the specimens, instead of anti-
mouse fibrinogen rabbit serum. Each anti-
serum wNas diluted wxith PBS in the ratio
1:79 before use. Tumours of 5 animals from
the control group, and from each of the
groups treated wsith t-AMCHA and 10,000 u/
kg of urokinase were cut into 1mm3 blocks,
fixed in 2.5%O glutaraldehyde, and subjected
to post-fixation in 2% osmium tetroxide in
0-2m phosphate buffer (pH 7-3). After
fixation, the specimens Aere dehydrated by a
graded ethanol series, and embedded in Epon
812. Five blocks per mouse, that is, 25 blocks
from each group, wiere cut into ultra-thin
sections, wNhich wA-ere double-stained wArith
uranyl acetate and lead citrate, and observed
by Hitachi H-500 transmission electron
microscope.
On Day 23, animals were examined for the
development of metastases. The numbers of
metastatic foci on the pleural surfaces of
both lungs were counted with the naked eye.
The data wsere statistically analysed by
Krusskall- Wlallis test.
RESULTS
The mean numbers of pulmonary meta-
static foci of 10 mice were 21-2 + 25
44-1 + 2-3, and 7 0 + 1P9 (mean + s.e.) in
the control, urokinase- and t-AMCHA-
treated groups of mice respectively. Uro-
kinase increased the number of metastatic
foci (P < 0.05). On the other hand, in the
mice given t-AMCHA, the number of
metastatic foci was significantly lower
than in the untreated (P < 0.05). Invasion
of tumour cells into the vascular lumina
was observed in the primary foci excised
from the mice on the 12th day. Free
tumour cells were frequent in the sin-
usoidal vessels but rare in the veins. Out of
30 vessels of each of 5 animals, the
incidences of these with free tumour cells
were 29, 40 and 20% in control, urokinase-
and t-AMCHA-treated mice respectively.
The highest incidence in the urokinase-
treated group coincided with the largest
number of metastatic foci in the lungs of
this group. Thrombus formation associ-
ated with intravasated tumour cells was
rare in the control (13.700 of the vessels
containing tumour cells) and absent in the
urokinase-treated animals, but frequent in
the t-AMCHA-treated mice (450 of such
vessels) (Table). In the tumours of the
control mice, capillary endothelial cells
were torn apart at the sites ofinvasion and
tumour cells invaded the capillary.
TABLE.-Effect of tranexamic acid and
urokinase on thrombusformation in intra-
vasation site
No. of vessels with / Total with
tumour cells associated / intravasated





For each treatment there were 5 mice producing 5
blocks fiom which 100 vessels were observed.
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FIG. 1.-A small blood vessel in the tumour of a control mouse. The capillary endothelial lining has
been breached and tumour cells are invading the capillary lumen without thrombus formation.
T, tumour cell. x 3500.
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FIG. 2.-Tumour-cell invasion site of a control mouse. A small amount of fibrin is visible. The
endothelial cell has fully degenerated, whereas the tumour cells are maintaining their structure
comparatively well. T, tumour cell; F, fibrin; E, endothelial cell. x 3350.EFFECTS OF t-AMCHA AND UROKINASE ON METASTASIS
lumina without thrombus formation or
fibrin deposition (Fig. 1). Although a small
amount of fibrin formation was occasion-
ally seen at the invasion sites (Fig. 2),
fixed thrombus formation was not seen
with electron microscopy in the control
mice. However, in the mice treated with
t-AMCHA, few tumour cells were seen in
the vessels of the primary foci, and the
intravascular tumour cells were often
associated with thrombi (Fig. 3). These
thrombi were mainlycomposed ofplatelets
and polymerized fibrin identified by im-
munofluorescence tests using anti-mouse-
fibrinogen serum (Fig. 4), and by electron
microscopy as having specific periodicity
(Figs 5 & 6). Polymerized fibrin deposition
onthe surface oftheintravascular cellswas
evident in mice on t-AMCHA treatment.
Some platelets with pseudopodia were
closely associated with the tumour cells.
On the other hand, in the urokinase-
Fma. 3. A vein in the tumour of a mouse
treated with tranexamic acid (t-AMCHA).
A thrombus is seen in the capillary lumen. A
1 ,um section from a block embedded in
Epon 812. Toluidine-blue stain. x 570.
treated group, intravascular tumour cells
were frequent. Clusters of tumour cells
were prominent intravascularly in
primary tumour of this group (Fig. 7).
Amorphous faintly positive fluorescence
for fibrinogen was seen around the cells
(Fig. 8), though no polymerized fibrin
deposition was seen ultrastructurally
(Fig. 9).
DISCUSSION
The inhibitory effect of t-AMCHA on
spontaneous metastasis have been demon-
strated by Peterson (1968) with mouse
mammary carcinoma, and by Kodama &
Tonaka (1981) with rabbit V2 carcinoma.
Kodama & Tonaka (1978) also showed
that the administration of urokinase
accelerated the metastasis of rabbit V2
carcinoma. We also previously reported
that t-AMCHA decreased the number of
pulmonary metastases of Lewis lung
FIG. 4.-Immunotluorescence staining for
mouse fibrinogen. A specimen from a
t-AMCHA-treated mouse. Note the posi-
tively stained fibrin thrombus.
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FIG. 5.-The same specimen as shown in Fig. 3. The tumour cells in the vessel are surrounded by
fibrin. P, platelet. x 5700. Inset: High magnification of fibrin deposition. Platelet with many
pseudopodia adheres to the fibrin threads and villi of the tumour cell. x 23,000.
FIG. 6. A specimen from a mouse treated with t-AMCHA. Fibrin deposition on the surface of a
tumour cell. Polymerized fibrin has a specific periodic pattern of 20-23 nm. x 83,000.
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FI. 8.-Immunofluorescent stain for fibrino- FIG. 7. Light micrograph of the vein of the gen. Free tumour cells are present in the
tumour ofa mouse administered urokinase. capillary lumen of a mouse in the same
Many free tumour cells are seen in the group as that ofFig. 7. Specific fluorescence
small vein (arrow). H&E. x 290. for fibrinogen around the tumour cells.
x 525.
carcinoma implanted into the foot pads,
but, on the other hand, urokinase in-
creased the number of the metastases in
the mice (Tanaka et al., 1981). The use oft-
AMCHA and urokinase can be expected to
clarify the role of fibrin in metastasis,
because t-AMCHA is an inhibitor of the
activation of plasminogen, but slightly
inhibits the esterolytic and caseinolytic
activities ofplasmin (Iwamoto et al., 1968,
1975; Abiko et al., 1969)-in other
words, t-AMCHA inhibits highly specific-
ally the fibrinolytic activity of plasmin,
while urokinase is an activator of plas-
minogen. In the previous study (Tanaka et
al., 1981), light microscopy showed that, in
mice treated with t-AMCHA, the tumour
cells in the vessels of primary foci were
often associated with thrombi. Light
microscopy, however, cannot resolve the
fine details of the tumour-cell-fibrin inter-
action. Immunofluorescence studies gave
positive reactions for fibrinogen around
the tumour cells of t-AMCHA-treated as
well as urokinase-treated mice. This pro-
cedure does not differentiate fibrin from
fibrinogen and related materials (Emeis
et al., 1981), though various types of
fibrin(ogen)-related materials, such as
fibrinogen, fibrin monomer, fibrin and
fibrin(ogen) degradation products (FDPs)
might be present in tissues, and all these
substances had to be positively stained
with antifibrinogen serum. Positive reac-
tion in the urokinase-treated group, there-
fore, should be not for fibrin but for
fibrinogen and/or FDPs, because electron
microscopy did not prove the presence of
obvious polymerized fibrin. The present
electron microscopy clearly revealed that
polymerized fibrin showing periodicity
were deposited on the tumour cells at
invasion sites of mice treated with t-
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FIG. 9.-Specimen from a mouse in the same group as that of Figs 7 and 8. No fibrin
deposition is seen around the tumour cells in the sinusoidal capillary. x 4150.
AMCHA. This periodic pattern is charac-
teristic of the structure of polymerized
fibrin (Hawn & Porter, 1947; Kay &
Cuddingan, 1967). Tumour cells invaded
the blood vessels via the site of breaching
of the endothelial cells. Although a small
amount offibrin deposition was seen at the
invasion site in the control mice, the
invading cells were not associated with
thrombus formation in control and
urokinase-treated mice. This suggests that
no thrombus formation was due to the
fibrinolytic activity of plasmin, which can
rapidly convert a small amount offibrin to
FDPs at the invasion sites. Polymerized
stable fibrin deposition around tumour
cells, and thrombi composed of fibrin and
platelets were characteristic findings in
mice under t-AMCHA administration,
which does not participate in the process
ofthrombus formation at all, in spite ofits
antifibrinolytic action (Tomikawa, 1975).
This indicates that the fibrinolytic activity
of Lewis lung carcinoma cell alone, and/or
that of host animals induced by fibrin
deposition, might be inhibited by t-
AMCHA. Lewis lung carcinoma has been
shown by Kohga et al. (1981) to have
relatively low fibrinolytic activity; there-
fore inhibition of fibrin resolution induced
by continuous administration of t-
AMCHA could finally cause formation of
thrombi visible in light microscopy, and
consequently, these thrombi, associated
with tumour cells, prevented cell detach-
ment and cell release, forming secondary
metastasis from primary foci.
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